Clinical Trial Update: A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of faldaprevir, TD-6450 and other antivirals in genotype 1b Hepatitis C; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Faldaprevir (faldaprevir)
• TD-6450 (TD-6450)

Snippet

Sponsor: Trek Therapeutics, PBC | Conditions: Hepatitis C Viral Infection, Chronic Hepatitis C | Phase 2 | Status: COMPLETED